Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Precancerous Conditions 1Lymphatic Metastasis 1Liver Neoplasms 1Gallbladder Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma 1Biliary Tract Neoplasms 1

Interventions

temsirolimus 2Sunitinib 2Sorafenib 2Axitinib 2sonidegib 1niraparib 1lenvatinib 1gadolinium ethoxybenzyl DTPA 1donafenib 1Transurethral Resection of Prostate 1Therapeutics 1Phlebotomy 1Palliative Care 1Mitomycin 1Methylation 1Maintenance 1Interviews as Topic 1Hyperthermic Intraperitoneal Chemotherapy 1HhAntag691 1Hepatectomy 1Fatty Acids, Omega-6 1Endoscopy 1Cetuximab 1Breath Tests 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Carcinoma × Methylation × Clear all
NCT06358222 2025-05-18

Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan

Shanghai Chest Hospital

Recruiting
200 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡